A Prospective, Multi-Center, Randomized, Double-Masked, Positive-Controlled Phase 3 Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution Compared to Prednisolone Acetate Ophthalmic Suspension (1%) in Patients with Non-Infectious Anterior Segment Uveitis Save

Date Added
September 13th, 2016
PRO Number
Pro00058667
Researcher
Lynn Perry
Keywords
Vision/ Eye
Summary

This study is using an investigational drug delivery system that is placed on the eye which generates a mild electric current which helps deliver study drug or placebo (depending on which group the patient is randomized) to the eye that has been diagnosed with uveitis

Institution
MUSC
Recruitment Contact
Carol Bradham
843-792-2338
bradhamc@musc.edu

Change_preferences

-- OR --

Create_login